Reversal of excessive oral anticoagulation with a low oral dose of vitaminK-1 compared with acenocoumarine discontinuation. A prospective, randomized, open study
Cg. Fondevila et al., Reversal of excessive oral anticoagulation with a low oral dose of vitaminK-1 compared with acenocoumarine discontinuation. A prospective, randomized, open study, BL COAG FIB, 12(1), 2001, pp. 9-16
We performed a prospective, randomized, open study in 109 outpatients under
chronic anticoagulation with acenocoumarine, presenting with International
Normalized Ratios (INRs) greater than or equal to 6.0 and no or minor blee
ding. All the patients withheld one dose of acenocoumarine; in addition, a
treated group also received 1 mg oral vitamin K-1. We aimed at a post-inter
vention INR < 6.0, with a target zone of 2,0-4.0. The INRs were lowered fro
m a mean of 8.1 +/- 1.7 to 4.9 +/- 2.5 in the controls (P= 0.0000) and from
8.4 +/- 2.4 to 3.3 +/- 3 in the treated patients (P = 0.0000). There were
no differences in the percentage of patients with postintervention INRs < 6
.0 or within the therapeutic zone. One-third of the treated patients and on
ly 2% of the controls reached INRs < 2.0 (P= 0.0003). Oral vitamin K-1 offe
red no advantageto the simple discontinuation of one dose of acenocoumarine
. A substantial number of treated patients were consequently exposed to und
er-anticoagulation. Blood Coagul Fibrinolysis 12:9-16 (C) 2001 Lippincott W
illiams & Wilkins.